Response to "Refining FIB-4-based risk stratification in adverse drug reactions".

Henze J, Goette L, Dormann H, Schneider CV, Meeßen C, Knüppel-Ruppert A, Kriegisch-Stumpf A, Schwab M, Stingl JC, Just KS

Open source

DOI: 10.1007/s00228-026-04101-y
Published: 2026 Jun 17
Container: European journal of clinical pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04101-y,
  title = {Response to "Refining FIB-4-based risk stratification in adverse drug reactions".},
  author = {Henze J and Goette L and Dormann H and Schneider CV and Meeßen C and Knüppel-Ruppert A and Kriegisch-Stumpf A and Schwab M and Stingl JC and Just KS},
  year = {2026},
  journal = {European journal of clinical pharmacology},
  doi = {10.1007/s00228-026-04101-y},
  url = {https://doi.org/10.1007/s00228-026-04101-y}
}

RIS

TY  - JOUR
TI  - Response to "Refining FIB-4-based risk stratification in adverse drug reactions".
AU  - Henze J
AU  - Goette L
AU  - Dormann H
AU  - Schneider CV
AU  - Meeßen C
AU  - Knüppel-Ruppert A
AU  - Kriegisch-Stumpf A
AU  - Schwab M
AU  - Stingl JC
AU  - Just KS
PY  - 2026
JO  - European journal of clinical pharmacology
DO  - 10.1007/s00228-026-04101-y
UR  - https://doi.org/10.1007/s00228-026-04101-y
ER  -

APA

J, H., L, G., H, D., CV, S., C, M., A, K., A, K., M, S., JC, S., & KS, J. (2026). Response to "Refining FIB-4-based risk stratification in adverse drug reactions".. European journal of clinical pharmacology. https://doi.org/10.1007/s00228-026-04101-y

Source records

pubmed · retrieved 2026-09-25T20:09:31.979Z